| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Revenue | $1.20B | +22.6% |
| Cost of Revenue | $450.4M | +13.4% |
| Gross Profit | $752.1M | +28.9% |
| R&D Expense | $296.2M | +9.9% |
| SG&A Expense | $184.5M | +10.1% |
| Operating Income | $41.1M | +178.1% |
| Interest Expense | $13.2M | +96.1% |
| Pre-tax Income | $49.4M | +284.0% |
| Income Tax | -$20.4M |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $697.9M | +27.4% |
| Short-term Investments | $451.5M | -0.9% |
| Accounts Receivable | $140.6M | +2.4% |
| Current Assets | $1.51B | +16.4% |
| Total Assets | $2.72B | +22.2% |
| Current Liabilities | $544.8M | -35.0% |
| Total Liabilities | $1.26B | +43.0% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $300.9M | +53.7% |
| Capital Expenditures | $5.7M | -9.8% |
| Investing Cash Flow | -$237.0M | -352.6% |
| Financing Cash Flow | $82.3M | +7700.3% |
| Free Cash Flow | $295.1M | +55.8% |
| +1.6% |
| Net Income | $69.8M | +1243.8% |
| EPS (Basic) | $0.83 | +1285.7% |
| EPS (Diluted) | $0.81 | +1257.1% |
| Stockholders' Equity |
| $1.46B |
| +8.5% |